Skip to main content

Table 2 (A) Fragment of raw output with unique read counts of HPV16 and HPV18 E2, E67, and E6* with expression levels in CASKI and HELA cell lines. (B) Output of the same probes on a positive control sample containing hrHPV amplicons

From: Targeted RNA next generation sequencing analysis of cervical smears can predict the presence of hrHPV-induced cervical lesions

A

B

CELL LINE

 

CASKI

  

HELA

 

amplicon controls

HPV16E2_smMIP1

237

197

286

0

0

0

868

HPV16E2_smMIP2

584

443

705

0

0

0

1533

HPV16E2_smMIP3

655

738

1056

0

0

0

1552

HPV16E2_smMIP4

37

23

45

0

0

0

81

HPV16E6*I smMIP5

871

842

1291

0

0

0

200

HPV16E6_smMIP6

636

576

905

0

0

0

1886

HPV16E6_smMIP7

25

19

41

0

0

0

926

HPV16E7_smMIP8

1654

1661

2369

0

0

0

1446

HPV18E2_smMIP1

0

0

0

57

44

45

426

HPV18E2_smMIP2

0

0

0

0

0

0

197

HPV18E2_smMIP3

0

0

0

0

0

0

2506

HPV18E6*I_smMIP4

0

0

0

11560

9834

9875

869

HPV18E6_smMIP5

0

0

0

989

882

815

543

HPV18E6_smMIP6

0

0

0

308

270

240

107

HPV18E7_smMIP7

0

0

0

13202

11229

11451

7548